DDX49 as a novel prognostic biomarker regulates colorectal cancer cell proliferation through the TIMM44-PI3K-AKT pathway
DDX49, a potential prognostic biomarker, promotes cell proliferation by TIMM44-PI3K-AKT pathway, which may offer a target for clinical anti-tumor therapy.
Authors
- Zhipeng Yin (ORCID: https://orcid.org/0009-0009-4400-3119)
- Gang Gao (ORCID: https://orcid.org/0000-0003-4259-9683)
- Baoyu Huang (ORCID: https://orcid.org/0000-0002-9682-8296)
- Yang Miao (ORCID: https://orcid.org/0000-0002-4127-2980)
- Longhai Li (ORCID: https://orcid.org/0000-0003-4387-8932)
Institutions
- Bozhou People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.3389/fonc.2025.1707092
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00